FDA Delays Rule On Regulating Tobacco Until 2018

Law360, New York (March 20, 2017, 6:42 PM EDT) -- The U.S. Food and Drug Administration on Monday said it’s pushing back the implementation of a rule pertaining to the circumstances under which tobacco products can be regulated as medical products until March 2018, after receiving criticism from pharmaceutical organizations backed by Ropes & Gray LLP and Sidley Austin LLP.

The petition filed by the Medical Information Working Group, the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization took issue with how the FDA changed its definition of intended uses of products, namely...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.